No one wanted $Hims at $15 Now everyone wants it at $30 The whole planet will be chasing it at $500

🚨 CITI SAYS AMAZON IS NOT A REPLACEMENT FOR $HIMS

$OSCR You hardly ever hear of a company reiterating guidance twice within a month and a half. We are taking over 70% QoQ revenue growth… Double digit Q1 operating margins… AND… while others are STRUGGLING to keep members… Oscar added ~1 MILLION… yes… 1 MILLION increase

Mark Bertolini Mark T. Bertolini CEO of Oscar Health $OSCR: "2026 is our year. We are positioned to significantly expand margins, return to profitability, and accelerate financial performance toward our long-term targets. Our growth reflects 12 years of navigating the individual market

$OSCR Nephron Research just initiated coverage on Oscar Health with a Buy rating and $22 Price Target – April 20, 2026. For anyone new to the name: Nephron is a New York-based independent leader in healthcare investment research. They provide high-quality, conflict-free

$OSCR - BUY RATING $22 Now we are talking :)

$OSCR It’s been a while since I’ve seen you up here :)

$OSCR MARK BERTOLINI FULL VIDEO AT MEDICARIAN The Future of Healthcare ICHRA Consumer Choice vimeo.com/1185301722

$HIMS X 🇨🇦

$SOFI is down, and many would only look at the stock price and make a decision. This is a company growing revenue 40% and doubling EPS. Yes, the Tech Platform part of the business is a dud. But you get a higher multiple because of high growth. The overall business is

$HIMS THE PEPTIDE SUPPLY CHAIN --- JUST 5 COMPANIES IN CHINA CONTROL ~90% OF THE AMINO ACIDS 🤯 Mansi: "Before any peptide is produced, you need its API, which stands for 'active pharmaceutical ingredient', and right now China supplies most of the world's API" "The top

$OSCR “At Oscar, we have 40 large language models on the back end of the business and we have three agentic AI bots on the front end… We're now 3.5 million, going down to three.. We're at 19 billion. And we have the same number of employees... three years later." - Mark B. CEO

🚨 BREAKING: DEUTSCHE BANK LOWERS $HIMS PRICE TARGET TO $25 FROM $28, MAINTAINS HOLD RATING

$OSCR Creating a seamless insurance shopping experience can and will increase ICHRA adoption. If it isn’t easy, employers won’t want to switch. Lucie makes it seamless.

$HIMS Peptide Revolution will be BIGGER than AI 🚀 2016: GPUs = Gaming 2026: Peptides = GLP-1s The next trillion-dollar health megatrend just started. Don’t sleep on it. $NVO $LLY #peptides

Let’s just say $OSCR ‘s expected revenue for Q1 2026… Is literally off this chart.

Dope vid

WE ALL BLEED RED Kinda…. I expected it to be close to 4.9-5 billion net of RA… but they accrued RA in Q1 higher to reflect trends from 2025 it appears… So Q2-Q4 will be higher than my estimated due to lower RA… Gross premiums were in-line pretty close… The decrease in MLR was offset by RA

In 2021, Joe Biden’s Energy Secretary Jennifer Granholm said, “The president does not control the price of gasoline.” What changed?

$OSCR 1. Massive earnings beat ✅ 2. Multiple analyst upgrades 🔜 3. Institutional buying 🔜 4. $30+ 🚀 🔜 How long will it take 😏